Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis (Q70670252)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477962%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

title

Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477962%20AND%20SRC:MED&resulttype=core&format=json

primary biliary cholangitis

13 October 2019

main subject

0 references

author name string

R E Poupon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477962%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

K Ouguerram

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477962%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

Y Chrétien

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477962%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

C Verneau

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477962%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

E Eschwège

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477962%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

T Magot

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477962%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

R Poupon

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477962%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

language of work or name

English

0 references

publication date

1 April 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477962%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477962%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477962%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477962%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

page(s)

577-582

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477962%20AND%20SRC:MED&resulttype=core&format=json

Dyslipoproteinaemia of liver disease

13 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

Lipoprotein abnormalities in patients with early primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

Lipoprotein abnormalities in primary biliary cirrhosis: information concerning control of plasma high density lipoprotein levels

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

Improved techniques for the separation of serum lipoproteins by density gradient ultracentrifugation: visualization by prestaining and rapid separation of serum lipoproteins from small volumes of serum

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

Bile acid-lipoprotein interactions: effects of ursodeoxycholic acid (ursodiol)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

Modulation of bile secretion by hepatic low-density lipoprotein uptake and by chenodeoxycholic acid and ursodeoxycholic acid treatment in the hamster

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

Ursodeoxycholic acid increases low-density lipoprotein binding, uptake and degradation in isolated hamster hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

In vivo effect of simvastatin on lipoprotein cholesteryl ester metabolism in normocholesterolemic volunteers.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

Effect of ursodeoxycholic acid on biliary lipid coupling and on cholesterol absorption during fasting and eating in subjects with cholesterol gallstones

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

Effect of ursodeoxycholic acid treatment on ileal absorption of bile acids in man as determined by the SeHCAT test

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

Lipoprotein pattern and plasma lipoprotein lipase activities in patients with primary biliary cirrhosis. Relationship with increase of HDL2 fraction in Lp-X-positive and Lp-X-negative subjects

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

Increased concentration of high density lipoprotein in plasma and decreased platelet aggregation in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

Plasma lipoproteins and apoproteins in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

Apolipoprotein E-rich HDL in patients with homozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

Factors affecting the rate of catalyzed transfer of cholesteryl esters in plasma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170408

7 January 2021

Identifiers

DOI

10.1002/HEP.1840170408

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477962%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference